 |
市場調查報告書
商品編碼
1981024
2026-2034年全球多汗症治療市場規模、佔有率、趨勢和成長分析報告Global Hyperhidrosis Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034 |
||||||
預計到 2034 年，多汗症治療市場規模將達到 1,242,970,000 美元，高於 2025 年的 765,080,000 美元，預計從 2026 年到 2034 年的複合年成長率將達到 5.54%。
隨著人們對多汗症的認知不斷提高，全球多汗症治療市場需求日益成長。多汗症影響著全球數百萬人，並可能嚴重影響他們的生活品質和自信心。治療方法包括外用藥物、口服藥物、肉毒桿菌注射以及微波療法和手術等先進療法。
人們對現有治療方法的認知度提高以及診斷率的上升是推動市場成長的關鍵因素。醫療機構正在採用最新的治療方案，以期長期緩解多汗症症狀。此外，美容皮膚科診所提供的專業多汗症治療也促進了市場滲透率的提升。
隨著醫學研究不斷發展出更有效的治療方法，多汗症治療市場的未來前景仍然光明。人們對微創手術和皮膚科治療日益成長的興趣預計將推動市場需求。隨著醫療保健服務的普及和公眾意識的提高，預計會有更多患者尋求治療。
目錄
第1章：引言
第2章執行摘要
第3章 市場變數、趨勢與框架
- 市場譜系展望
- 滲透率和成長前景分析
- 價值鏈分析
- 法律規範
- 標準與合規性
- 監管影響分析
- 市場動態
- 市場促進因素
- 市場限制因素
- 市場機遇
- 市場挑戰
- 波特五力分析
- PESTLE分析
第4章：全球多汗症治療市場：按類型分類
- 市場分析、洞察與預測
- 腋窩多汗症
- 手掌多汗症
- 足底多汗症
- 其他類型
第5章 全球多汗症治療市場：依治療方法分類
- 市場分析、洞察與預測
- 局部治療
- 口服藥物
- 肉毒桿菌注射
- 離子泳
- 手術治療
第6章：全球多汗症治療市場：依年齡層別分類
- 市場分析、洞察與預測
- 50歲以下
- 超過50歲
第7章：全球多汗症治療市場：依最終用戶分類
- 市場分析、洞察與預測
- 醫院
- 門診手術中心
- 皮膚科診所
- 其他最終用戶
第8章 全球多汗症治療市場：按地區分類
- 區域分析
- 北美市場分析、洞察與預測
- 美國
- 加拿大
- 墨西哥
- 歐洲市場分析、洞察與預測
- 英國
- 法國
- 德國
- 義大利
- 俄羅斯
- 其他歐洲國家
- 亞太市場分析、洞察與預測
- 印度
- 日本
- 韓國
- 澳洲
- 東南亞
- 其他亞太國家
- 拉丁美洲市場分析、洞察與預測
- 巴西
- 阿根廷
- 秘魯
- 智利
- 其他拉丁美洲國家
- 中東和非洲市場分析、洞察與預測
- 沙烏地阿拉伯
- UAE
- 以色列
- 南非
- 其他中東和非洲國家
第9章 競爭情勢
- 最新趨勢
- 公司分類
- 供應鏈和銷售管道合作夥伴（根據現有資訊）
- 市場佔有率和市場定位分析（基於現有資訊）
- 供應商情況（基於現有資訊）
- 策略規劃
第10章：公司簡介
- 主要公司的市佔率分析
- 公司簡介
- AbbVie Inc
- Avanor Healthcare Ltd
- Brickell Biotech Inc
- Dermadry Laboratories Inc
- Dermavant Sciences Inc
- Hugel Inc
- Eirion Therapeutics Inc
- Eli Lilly And Company
- Intas Pharmaceuticals Ltd
- Kaken Pharmaceutical Co. Ltd
- Maruho Co. Ltd
- MiraDry Inc
- SweatBlock
The Hyperhidrosis Treatment Market size is expected to reach USD 1242.97 Million in 2034 from USD 765.08 Million (2025) growing at a CAGR of 5.54% during 2026-2034.
The global hyperhidrosis treatment market is experiencing growing demand as awareness about excessive sweating disorders increases. Hyperhidrosis affects millions of individuals worldwide and can significantly impact quality of life and confidence. Treatment options include topical medications, oral drugs, botulinum toxin injections, and advanced procedures such as microwave therapy and surgical interventions.
Rising awareness about available treatment options and increasing diagnosis rates are key drivers of market growth. Healthcare providers are adopting modern therapeutic solutions that provide longer-lasting relief from excessive sweating. In addition, aesthetic and dermatology clinics are offering specialized treatments for hyperhidrosis, contributing to expanding market adoption.
The future outlook for the hyperhidrosis treatment market remains positive as medical research continues to develop more effective therapies. Growing interest in minimally invasive procedures and dermatological treatments will likely drive demand. As healthcare access improves and awareness increases, more patients are expected to seek treatment for this condition.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
MARKET SEGMENTATION
By Type
- Axillary Hyperhidrosis
- Palmar Hyperhidrosis
- Plantar Hyperhidrosis
- Other Types
By Treatment
- Topical Treatment
- Oral Medication
- Botulinum Toxin Injections
- Iontophoresis
- Surgical Treatment
By Age
- Below 50 years
- Above 50 years
By End-user
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- Other End-Users
COMPANIES PROFILED
- AbbVie Inc, Avanor Healthcare Ltd, Brickell Biotech Inc, Dermadry Laboratories Inc, Dermavant Sciences Inc, Hugel Inc, Eirion Therapeutics Inc, Eli Lilly and Company, Intas Pharmaceuticals Ltd, Kaken Pharmaceutical Co Ltd, Maruho Co Ltd, miraDry Inc, SweatBlock
- We can customise the report as per your requirements.
TABLE OF CONTENTS
Chapter 1. PREFACE
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
- 1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources
Chapter 2. EXECUTIVE SUMMARY
- 2.1. Market Snapshot
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK
- 3.1. Market Lineage Outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Value Chain Analysis
- 3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
- 3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
- 3.6. Porter's Five Forces Analysis
- 3.7. PESTLE Analysis
Chapter 4. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)
- 4.1. Market Analysis, Insights and Forecast Type
- 4.2. Axillary Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.3. Palmar Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.4. Plantar Hyperhidrosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 4.5. Other Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 5. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY TREATMENT 2022-2034 (USD MN)
- 5.1. Market Analysis, Insights and Forecast Treatment
- 5.2. Topical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.3. Oral Medication Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.4. Botulinum Toxin Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.5. Iontophoresis Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 5.6. Surgical Treatment Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 6. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY AGE 2022-2034 (USD MN)
- 6.1. Market Analysis, Insights and Forecast Age
- 6.2. Below 50 years Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 6.3. Above 50 years Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 7. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY END-USER 2022-2034 (USD MN)
- 7.1. Market Analysis, Insights and Forecast End-user
- 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.4. Dermatology Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
- 7.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)
Chapter 8. GLOBAL HYPERHIDROSIS TREATMENT MARKET: BY REGION 2022-2034(USD MN)
- 8.1. Regional Outlook
- 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Type
- 8.2.2 By Treatment
- 8.2.3 By Age
- 8.2.4 By End-user
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
- 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Type
- 8.3.2 By Treatment
- 8.3.3 By Age
- 8.3.4 By End-user
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
- 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Type
- 8.4.2 By Treatment
- 8.4.3 By Age
- 8.4.4 By End-user
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
- 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Type
- 8.5.2 By Treatment
- 8.5.3 By Age
- 8.5.4 By End-user
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
- 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Type
- 8.6.2 By Treatment
- 8.6.3 By Age
- 8.6.4 By End-user
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa
Chapter 9. COMPETITIVE LANDSCAPE
- 9.1. Recent Developments
- 9.2. Company Categorization
- 9.3. Supply Chain & Channel Partners (based on availability)
- 9.4. Market Share & Positioning Analysis (based on availability)
- 9.5. Vendor Landscape (based on availability)
- 9.6. Strategy Mapping
Chapter 10. COMPANY PROFILES OF GLOBAL HYPERHIDROSIS TREATMENT INDUSTRY
- 10.1. Top Companies Market Share Analysis
- 10.2. Company Profiles
- 10.2.1 AbbVie Inc
- 10.2.2 Avanor Healthcare Ltd
- 10.2.3 Brickell Biotech Inc
- 10.2.4 Dermadry Laboratories Inc
- 10.2.5 Dermavant Sciences Inc
- 10.2.6 Hugel Inc
- 10.2.7 Eirion Therapeutics Inc
- 10.2.8 Eli Lilly And Company
- 10.2.9 Intas Pharmaceuticals Ltd
- 10.2.10 Kaken Pharmaceutical Co. Ltd
- 10.2.11 Maruho Co. Ltd
- 10.2.12 MiraDry Inc
- 10.2.13 SweatBlock
